Publications de la R&D d'Unicancer


Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer.

P. Cottu et al, Ann Oncol. 2018 Dec 1;29(12):2334-2340. doi: 10.1093/annonc/mdy448.


Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial

P. J.A.M. Brouwers et al., Radiother Oncol. 2016 Jul;120(1):107-13.


Breast cancer screening: On our way to the future [article in French]

Delaloge S et al., Bull Cancer. 2016 Jul 26.


70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Cardoso F et al., N Engl J Med. 2016 Aug 25;375(8):717-29.